Northwire Canada EditionTuesday, August 25, 2026
Northwire
GOLD 4723.60 +0.6% SILVER 68.95 +0.5% COPPER 6.71 +1.6% OIL 80.65 −5.1% PALLADIUM 1339.50 −1.8% OTMC 0.670 +50.6% OPW 0.130 +4.0% HI 0.170 +13.3% VCU 1.33 +1.5% DLTA 0.175 −5.4% EMO 0.400 −1.2% GR 0.070 +0.0% MGG 0.395 +1.3% EVI 0.520 −5.5% AVL 9.72 +21.4% VCG 1.53 +11.7% TTS 2.30 −11.5% SCMI 1.88 +1.6% RIO 3.63 +6.5% PUMA 0.120 −7.7% TRR 0.350 −2.8% GOLD 4723.60 +0.6% SILVER 68.95 +0.5% COPPER 6.71 +1.6% OIL 80.65 −5.1% PALLADIUM 1339.50 −1.8% OTMC 0.670 +50.6% OPW 0.130 +4.0% HI 0.170 +13.3% VCU 1.33 +1.5% DLTA 0.175 −5.4% EMO 0.400 −1.2% GR 0.070 +0.0% MGG 0.395 +1.3% EVI 0.520 −5.5% AVL 9.72 +21.4% VCG 1.53 +11.7% TTS 2.30 −11.5% SCMI 1.88 +1.6% RIO 3.63 +6.5% PUMA 0.120 −7.7% TRR 0.350 −2.8%
Financings

AlphaGen Announces Private Placement of Up to $2.5 million

AIC · Price

Executive Summary

  • AlphaGen Intelligence Corp. announced a non‑brokered private placement of up to 10,000,000 units at $0.25 per unit, targeting gross proceeds of up to $2,500,000.
  • Each unit consists of one common share and half of a share purchase warrant; the full warrant allows purchase of an additional share at $0.40 for two years.
  • Net proceeds are earmarked for general working‑capital needs, with possible finder’s fees; closing is expected within 45 days of price protection, subject to shareholder and regulatory approvals.

Key Details

  • Offering Size: Up to 10,000,000 units (each $0.25) → Maximum gross proceeds: $2,500,000.
  • Unit Composition: 1 common share + ½ share purchase warrant.
  • Warrant Terms: Each whole warrant permits purchase of one additional share at $0.40 per share; exercisable for two years from issuance.
  • Use of Proceeds: General working capital; may include payment of finder’s fees related to the offering.
  • Holding Period: All securities subject to a statutory four‑month hold period under applicable securities legislation.
  • Closing Timeline: Expected on or before 45 days after the price protection date, contingent upon shareholder approval and required regulatory clearances (including CSE acceptance).
  • Regulatory Notes: Securities not registered in the United States; offering unavailable to U.S. persons absent exemption.

Notable Quotes

(No executive quotes provided in the release.)

Read the original news release →

More from AlphaGen Intelligence Corp.